Figure 1.
Long-term outcome of CML patients treated with TKI as initial therapy according to age group. (A) Event-free survival. (B) Transformation-free survival. (C) Overall survival.
Long-term outcome of CML patients treated with TKI as initial therapy according to age group. (A) Event-free survival. (B) Transformation-free survival. (C) Overall survival.